Mangangot, Mark Caleb R.

HRN: 24-14-40  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/15/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/15/2025
01/22/2025
IV
650 Mg
Q8
AGE; PCAP
Waiting Final Action 
01/18/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/18/2025
01/24/2025
IV
50mg
Q8h
Infectious Diarrhea
Waiting Final Action 
01/18/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/18/2025
01/24/2025
IV
50mg
Q8h
Infectious Diarrhea
Waiting Final Action 
01/18/2025
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
01/18/2025
01/23/2025
PO
1.6 Ml
OD
T/C Infectious Diarrhea
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: